Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Should You Buy Moderna in March?


Moderna (NASDAQ: MRNA) has been one of the hottest stocks to buy over the past year, soaring more than 340% while the S&P 500 has increased by just 30% during that time. The company's COVID-19 vaccine has put Moderna on the map with investors, sending its market cap from less than $10 billion to more than $52 billion. And if its CEO is right about COVID-19 being around forever, the vaccine could deliver recurring income for many years. 

However, Moderna's shares have been crashing over the past month despite a strong earnings report. Is March a good time to load up on the stock or should investors wait for more of a dip in price before investing in the company?

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments